Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma.
Gisela WeizMaria I MolejonMariana MalviciniCaecilia H C SukowatiClaudio TiribelliGuillermo MazzoliniJavier D BrecciaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Our results provide evidence that 4MUR may be used as an effective HCC therapy, without damaging non-tumoural cells or other organs, most probably due to the specific targeting.